Speakers
Chris Arendt, Ph.D.
CSO, Head of Research
Takeda
David Baker, Ph.D.
Investigator, Howard Hughes Medical Institute and Professor, Biochemistry and Director, Institute for Protein Design
University of Washington
Vanessa Bhark
Principal, Strategic Investment Fund
Gates Foundation
Mary Brunkow, Ph.D.
Senior Project Manager, Phenome Health and Program Manager, Genetics
Institute for Systems Biology
Simone Fishburn, Ph.D.
VP & Editor in Chief
BioCentury Inc.
Chris Garabedian
Portfolio Manager, PXV Fund and CEO,
Xontogeny
Hans‑Peter Gerber, Ph.D.
Chief Scientific Officer
Sutro Biopharma
DANIELLE GOLOVIN, PH.D.
Senior Biopharma Analyst
BioCentury Inc.
Claire Gustafson, Ph.D.
Assistant Investigator
Allen Institute for Immunology
Selina Koch, Ph.D.
Executive Editor, Head of Intelligence & Research
BioCentury Inc.
Julie Krop, M.D.
Chief Medical Officer
DiaMedica Therapeutics
William McKeon
President & CEO, Texas Medical Center, and Board Member
TMC Venture Fund
Vishal Mehta
Founder & CEO
Ubuntu Research
Phil Moquist, Ph.D.
Director of ADC Chemistry
Pfizer
Ramlah Nehring, Ph.D.
Global Head of Partnerships and Transactions
Roche Diagnostics
Ujjwal Ratan
Head of ML and Data Science, Healthcare & Life Sciences
Amazon Web Services
Klaus Romero, M.D.
CEO
Critical Path Institute
Michael Salgaller, Ph.D.
Supervisory Specialist
NIH Office of Technology Transfer
Adrish Sannyasi
VP of Customer Solutions
Rhino Federated Computing
Jay Shendure, Ph.D., M.D.
Investigator, Howard Hughes Medical Institute and Professor of Genome Sciences
University of Washington
Swati Shree, MD
Associate Professor, Maternal Fetal Medicine Department of Obstetrics & Gynecology
University of Washington
Matthias Stephan, M.D., Ph.D.
Professor
Fred Hutchinson Cancer Center
Richard Tillyer, Ph.D.
Global Head, Discovery, Product Development and Supply
Johnson & Johnson Innovative Medicine
Karen Tkach Tuzman, Ph.D.
Director of Biopharma Intelligence and Head of Discovery and Preclinical Research
BioCentury Inc.
Ben Weintraub, Ph.D.
President
inThought Research
Linda Zuckerman, Ph.D.
Global Head, Biotherapeutics
Just-Evotec Biologics